Jackson Square Capital LLC boosted its holdings in shares of MetLife, Inc. (NYSE:MET - Free Report) by 50.8% during the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 12,528 shares of the financial services provider's stock after purchasing an additional 4,219 shares during the period. Jackson Square Capital LLC's holdings in MetLife were worth $1,026,000 as of its most recent filing with the SEC.
Other institutional investors also recently bought and sold shares of the company. Legal & General Group Plc lifted its holdings in shares of MetLife by 5.4% during the second quarter. Legal & General Group Plc now owns 5,299,800 shares of the financial services provider's stock worth $371,993,000 after purchasing an additional 269,246 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its holdings in shares of MetLife by 1.5% in the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 4,548,725 shares of the financial services provider's stock valued at $375,179,000 after acquiring an additional 68,579 shares in the last quarter. Nordea Investment Management AB increased its stake in shares of MetLife by 16.8% during the fourth quarter. Nordea Investment Management AB now owns 4,238,087 shares of the financial services provider's stock worth $347,735,000 after acquiring an additional 608,224 shares during the period. Stifel Financial Corp raised its holdings in MetLife by 5.0% during the third quarter. Stifel Financial Corp now owns 2,239,841 shares of the financial services provider's stock worth $184,744,000 after purchasing an additional 105,762 shares in the last quarter. Finally, FMR LLC lifted its position in MetLife by 5.4% in the third quarter. FMR LLC now owns 2,209,119 shares of the financial services provider's stock valued at $182,208,000 after purchasing an additional 112,491 shares during the period. 94.99% of the stock is currently owned by institutional investors and hedge funds.
MetLife Price Performance
Shares of NYSE MET traded up $0.94 during trading on Friday, reaching $86.83. The company had a trading volume of 5,168,506 shares, compared to its average volume of 2,672,899. The company has a current ratio of 0.16, a quick ratio of 0.16 and a debt-to-equity ratio of 0.51. The stock has a market capitalization of $60.12 billion, a PE ratio of 17.51, a price-to-earnings-growth ratio of 0.59 and a beta of 1.07. MetLife, Inc. has a twelve month low of $64.61 and a twelve month high of $89.05. The stock has a 50-day moving average price of $83.41 and a two-hundred day moving average price of $79.47.
MetLife Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 11th. Investors of record on Tuesday, February 4th will be paid a dividend of $0.545 per share. This represents a $2.18 annualized dividend and a dividend yield of 2.51%. The ex-dividend date is Tuesday, February 4th. MetLife's payout ratio is 43.95%.
Analysts Set New Price Targets
A number of brokerages have recently issued reports on MET. Barclays increased their target price on MetLife from $90.00 to $96.00 and gave the stock an "overweight" rating in a research note on Monday, January 6th. Jefferies Financial Group boosted their target price on shares of MetLife from $89.00 to $95.00 and gave the stock a "buy" rating in a research report on Friday, September 27th. TD Cowen raised their price objective on shares of MetLife from $97.00 to $99.00 and gave the company a "buy" rating in a research note on Wednesday, November 27th. JPMorgan Chase & Co. upped their target price on shares of MetLife from $86.00 to $88.00 and gave the stock an "overweight" rating in a research report on Tuesday, January 7th. Finally, Wells Fargo & Company reduced their price target on shares of MetLife from $93.00 to $92.00 and set an "overweight" rating for the company in a research report on Tuesday, January 14th. One investment analyst has rated the stock with a hold rating and twelve have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $89.92.
Check Out Our Latest Stock Report on MET
About MetLife
(
Free Report)
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Recommended Stories
Before you consider MetLife, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MetLife wasn't on the list.
While MetLife currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
